Posttransplant Anti-GABAA Receptor Antibody-Associated Autoimmune Encephalitis

Claudio L Togni1, Karl Frontzek1, Maximilian Schubring-Giese1

  • 1From the Department of Neurology (C.L.T., L.L.I., I.J.); Institute of Neuropathology (K.F.), University Hospital Zurich and University of Zurich, Switzerland; Institute of Neurology (K.F.), Queen Square Brain Bank, University College London, United Kingdom; Cantonal Hospital of Zug (M.S.-G.), Baar; Swiss Epilepsy Center (L.L.I.), Klinik Lengg, Zurich; Neuroimmunology and MS Research (NIMS) (I.J.), Department of Neurology and University of Zurich, University Hospital Zurich; and Neuroimmunology Outpatient Clinic (I.J.), Center for Multiple Sclerosis, Neurocenter, Bellevue, Zurich, Switzerland.

Neurology
|March 7, 2024
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos

Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
399
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
831